Inhibikase Therapeutics
IKT
IKT
48 hedge funds and large institutions have $106M invested in Inhibikase Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
0.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
11
Reduced
6
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
$5.32M |
2 |
Geode Capital Management
Boston,
Massachusetts
|
$2.08M |
3 |
Blackstone Inc
New York
|
$5.14M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
$6.29M |
5 |
State Street
Boston,
Massachusetts
|
$776K |